PER 2.50% 8.2¢ percheron therapeutics limited

interest in antisense technology is growing ,...im sure that...

  1. 173 Posts.
    lightbulb Created with Sketch. 37
    interest in antisense technology is growing ,...im sure that there will be high interest in ANP if phase 2 trial is positive .LOVE IT especially the brutally low valuation of $ 22 million .

    “2019 could be seen in years to come as the start of a new era for RNA therapeutics.”
    https://wxpress.wuxiapptec.com/rna-focused-drug-development-emerging-as-a-dominant-treatment-modality-2/


    Ultragenyx snags option on antisense startup GeneTx
    https://www.fiercebiotech.com/biotech/ultragenyx-snags-option-antisense-startup-genetx


    J&J bets billions on RNA interference..
    https://www.biopharmadive.com/news/jj-bets-billions-on-rna-interference/538908/
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.0¢ 8.2¢ 7.9¢ $16.80K 210.0K

Buyers (Bids)

No. Vol. Price($)
1 24999 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 31992 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.